Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-15 Sale |
2024-05-17 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
69 | $430.93 | $29,734 | 49,831 (Indirect Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:37 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,034 | $425.7 | $2,142,974 | 49,831 (Indirect Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,603 | $421.77 | $1,519,637 | 59,579 (Indirect Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,804 | $420.79 | $2,021,475 | 63,182 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,295 | $420.24 | $1,804,931 | 75,858 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 4:41 pm |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
5,381 | $0 | $0 | 0 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 4:20 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $399 | $3,432,597 | 56,696 (Indirect Direct) |
View |
| 2023-06-15 Sale |
2023-06-20 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $349 | $3,002,447 | 65,299 (Indirect Direct) |
View |
| 2023-05-30 Sale |
2023-06-01 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
82 | $329.82 | $27,045 | 56,696 (Indirect Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 4:47 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,034 | $287.47 | $1,447,143 | 56,696 (Indirect Direct) |
View |
| 2023-02-22 Sale |
2023-02-24 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
2,401 | $294.33 | $706,679 | 66,444 (Indirect Direct) |
View |
| 2023-02-21 Sale |
2023-02-22 4:30 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
2,402 | $293.75 | $705,596 | 68,845 (Indirect Direct) |
View |
| 2023-02-14 Sale |
2023-02-16 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
6,398 | $298.68 | $1,910,962 | 75,745 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-14 4:53 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,887 | $298.92 | $1,460,816 | 82,143 (Indirect Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 5:39 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
22,173 | $303.93 | $6,738,991 | 45,418 (Indirect Direct) |
View |
| 2022-08-10 Sale |
2022-08-12 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
180 | $300.4 | $54,073 | 67,591 (Indirect Direct) |
View |
| 2022-08-09 Sale |
2022-08-10 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,690 | $300.67 | $1,710,817 | 67,771 (Indirect Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
133 | $251.19 | $33,408 | 64,900 (Indirect Direct) |
View |
| 2022-05-02 Sale |
2022-05-04 5:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
306 | $263.98 | $80,778 | 64,900 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-26 Tax Withholding |
2025-02-28 4:31 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
7,071 | $479.61 | 63,075 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,716 | $483.28 | 70,146 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:25 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
2,724 | $463.46 | 74,862 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
7,903 | $0 | 77,586 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,220 | $467.98 | 69,683 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
23,072 | $0 | 72,903 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 4:41 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director |
3,000 | $0 | 3,000 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 9:38 pm |
N/A 2034-06-17 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,714 | $431.79 | 49,831 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,499 | $424.01 | 63,182 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,373 | $420.58 | 63,182 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,177 | $422.74 | 75,858 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
26,634 | $0 | 83,330 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 5:43 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
442 | $29.65 | 5,381 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 4:20 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $0 | 56,696 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $187.53 | 56,696 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-02 5:06 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
827 | $15.87 | 4,939 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 5:54 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
695 | $18.87 | 4,112 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:30 pm |
N/A 2033-06-20 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:07 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $0 | 65,299 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $187.53 | 65,299 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 4:47 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
32,687 | $0 | 32,687 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 4:52 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
3,417 | $3.84 | 3,417 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:47 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,714 | $289.12 | 56,696 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:30 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,498 | $292.85 | 68,845 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,990 | $298.26 | 82,143 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,372 | $294.33 | 82,143 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:36 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
38,221 | $0 | 96,392 (Direct) |
View |
| 2022-12-06 Option Award |
2022-12-08 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
12,753 | $0 | 58,171 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 5:39 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
6,571 | $0 | 45,418 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 5:39 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
6,571 | $155.57 | 45,418 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 4:05 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
64 | $0 | 67,591 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
64 | $155.57 | 67,591 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-10 4:06 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
1,926 | $0 | 67,771 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-10 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
1,926 | $155.57 | 67,771 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:10 pm |
N/A 2032-06-15 |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
44,000 | $3.37 | 107,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:10 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
15,000 | $0 | 107,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:09 pm |
N/A 2032-06-07 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 5:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
7,246 | $227.86 | 65,206 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:54 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,126 | $232.51 | 72,452 (Direct) |
View |